Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
No Result
View All Result
Silicon Canals
No Result
View All Result

This Belgian-French biotech startup secures €20M funding to cure lung cancer completely

Editorial team by Editorial team
January 23, 2020
in News, (Crowd)funding, Startups
0
These 10 European tech startups want to help you improve your mental fitness
69
SHARES
LinkedInTwitterWhatsAppFacebook

PDC*line Pharma is a Belgian-French a clinical-stage biotech startup developing a new class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line) loaded with peptides derived from target tumour antigens. Founded in 2014 as a spin-off of the French Blood Bank, this startup comprises a team of skilled professionals based in Grenoble (France) and Liège (Belgium).

PDC*line Pharma focuses on lung cancer with a new candidate in phase 1b/2 clinical trial and neoantigens. The objectives of phase I/II study are to assess the safety, tolerability, immunogenicity and preliminary clinical activity of the drug candidate, PDC*lung01.

Secures €20M funding

Now, PDC*line Pharma has raised €20 million Series B funding. This funding has come almost two and a half years after its previous funding round that took place in 2017. PDC*line Pharma has raised the investment from five new investors such as Korean Investment Partners, the leading multi-billion dollar South-Korean fund, two further South-Korean funds, Shinhan-Cognitive Start-up Fund and UTC 2019 BIOVENTUREFUND, as well as two Belgian funds, SRIW (The Regional Investment Company of Wallonia) and Sambrinvest (the investment fund of Charleroi).

These join the existing investors such a Sambrinvest (the investment fund of Charleroi). They join the company’s historical investors: SFPI-FPIM, the Belgian Federal Holding and Investment Company, Noshaq Group (ex-Meusinvest), the Financière Spin-off Luxembourgeoise/INVESTSUD Group and a group of international business angels and well-known entrepreneurs.

Develops lung cancer vaccine!

PDC*lung01 comprises PDCline professional antigen-presenting cells loaded with HLA-A2 restricted peptides derived from six shared tumour antigens. PDC*line Pharma focuses on the development of PDC*lung01, a candidate for non-small-cell lung cancer (NSCLC) currently in phase I/II, and PDC*neo with neoantigens in preclinical development. In March 2019, the PDC*line Pharma granted an exclusive license to the LG Chem Life Sciences company in South Korea and an exclusive option in other Asian countries for the development and commercialisation of the PDC*lung01 cancer vaccine for lung cancer.

According to François Fontaine, general advisor to PDC*line Pharma at SFPI-FPIM, “PDC*line Pharma’s cancer vaccine platform is both highly innovative and meets an important medical need. It also has a clear societal impact for the Liège region, for Belgium and beyond. We welcome the continued strong support of the Walloon region and the new funding by existing and new investors.”

Main image picture credits: PDC*line Pharma

Stay tuned to Silicon Canals for more European technology news.

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Future Hamburg Award 2021
Future Hamburg Award 2021
Call for startups with innovative solutions for the future cities from all over the globe.
Call for startups with innovative solutions for the future cities from all over the globe. Show Less
Read more
Tags: fundingstartups
Share4Tweet13SendShare39

Featured events

Current Month

april

No Events

Partner content | Work with us

Amsterdam-based Lumicks raises €77.6M to provide instruments to reveal unique molecular, cellular interactions

Calling all European deep-tech scaleups: EIT Digital Challenge 2021 registration is now open

Amsterdam-based SaaS startup SwipeGuide raises €5M for international expansion; aims to double its staff in 2021

Innovation against climate change: what Blue Tulip Awards’ experts on Climate & Energy are looking for

Blue Tulip Awards’ experts of Finance & Prosperity: why COVID, regulations and digitisation boost innovation

Silicon Canals Jobs


Breaking news from Amsterdam | Partner

Amsterdam’s test automation startup SEGRON raises funding; looks to increase workforce by 30% by 2021-end

After tripling its revenue in 2020, Amsterdam-based fashion e-commerce startup Otrium raises €102.3M

Amsterdam’s IoT spacetech startup Hiber raises €26M to expand the world’s first global IoT satellite network

Amsterdam-based MessageBird acquires 24sessions to add video to its omnichannel offering; also acquires Hull

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info